UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 001-40227 FINCH THERAPEUTICS GROUP, INC. WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ (Exact Name of Registrant as Specified in its Charter) | D ...